Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-04-30 @ 8:22 PM
Study NCT ID:
NCT03363334
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2018-08-01
First Post:
2017-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP
Sponsor:
Rigel Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C-935788-055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None